Patents by Inventor Scott A. BOITANO

Scott A. BOITANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small molecule modulators of PAR2 and uses thereof
    Patent number: 11952379
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to a new class of small-molecules having a pyrazino-pyrimidine-dione (or related) structure which function as modulators (activators, inhibitors) of protease activated receptor type 2 (PAR2), and their use as therapeutics for the treatment of conditions involving PAR2 activity (e.g., asthma, chronic pain, cancer and/or vascular disorders).
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: April 9, 2024
    Assignees: Arizona Board of Regents on Behalf of the University of Arizona, Board of Regents, The University of Texas System
    Inventors: Scott A. Boitano, Josef Vagner, Theodore J. Price, Greg Dussor
  • COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE
    Publication number: 20230135877
    Abstract: Provided herein are compositions and methods for treating and preventing lung disease. In particular, provided herein are surfactant protein-A (SP-A) peptide analogies (e.g., SP-A peptidomimetics) and uses thereof in the treatment and prevention of lung disease (e.g., asthma or COPD).
    Type: Application
    Filed: April 8, 2021
    Publication date: May 4, 2023
    Inventors: Julie Ledford, Monica Kraft, Josef Vagner, Scott Boitano
  • PAR2 mimetic peptides and uses thereof
    Patent number: 11351264
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 2 (PAR2) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR2 activity.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: June 7, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Scott A. Boitano, Josef Vagner, Theodore J. Price
  • PAR3 mimetic peptides and uses thereof
    Patent number: 11306130
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 3 (PAR3) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR3 activity.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: April 19, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Josef Vagner, Scott A. Boitano, Theodore J. Price, Gregory O. Dussor
  • SMALL MOLECULE MODULATORS OF PAR2 AND USES THEREOF
    Publication number: 20210107909
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to a new class of small-molecules having a pyrazino-pyrimidine-dione (or related) structure which function as modulators (activators, inhibitors) of protease activated receptor type 2 (PAR2), and their use as therapeutics for the treatment of conditions involving PAR2 activity (e.g., asthma, chronic pain, cancer and/or vascular disorders).
    Type: Application
    Filed: April 9, 2019
    Publication date: April 15, 2021
    Inventors: Scott A. Boitano, Josef Vagner, Theodore J. Price, Gregory O. Dussor
  • PAR2 MIMETIC PEPTIDES AND USES THEREOF
    Publication number: 20190117785
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 2 (PAR2) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR2 activity.
    Type: Application
    Filed: March 31, 2017
    Publication date: April 25, 2019
    Applicants: Arizona Board of Regents on Behalf of the University of Arizona, Board of Regents, The University of Texas System
    Inventors: Scott A. BOITANO, Josef VAGNER, Theodore J. PRICE
  • PAR3 MIMETIC PEPTIDES AND USES THEREOF
    Publication number: 20190119349
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 3 (PAR3) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR3 activity.
    Type: Application
    Filed: March 31, 2017
    Publication date: April 25, 2019
    Applicants: Arizona Board of Regents on Behalf of The University of Arizona, Board of Regents, The University of Texas System
    Inventors: Josef VAGNER, Scott A. BOITANO, Theodore J. PRICE, Gregory O. DUSSOR